Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pinto, A.
Right arrow Articles by Di Fiore, P. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pinto, A.
Right arrow Articles by Di Fiore, P. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

5-Aza-2'-deoxycytidine induces terminal differentiation of leukemic blasts from patients with acute myeloid leukemias

A Pinto, V Attadia, A Fusco, F Ferrara, OA Spada and PP Di Fiore

In this study, the effects of 5-aza-2'-deoxycytidine on differentiation of human leukemic cells in primary suspension culture are reported for the first time. Morphological and functional differentiation was induced in cells from two acute monoblastic leukemias and two of three acute myeloid leukemias following repeated exposures to 1 mumol/L 5-aza- 2'-deoxycytidine. The observation that nontoxic concentrations of the drug are able to induce the in vitro differentiation of both monoblastic and myeloblastic leukemic cells into mature elements may encourage the exploitation of the differentiating properties of 5-aza- 2'-deoxycytidine in chemotherapy protocols for acute non-lymphoblastic leukemias.

Volume 64, Issue 4, pp. 922-929, 10/01/1984
Copyright © 1984 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
S. D. Nimer
Myelodysplastic syndromes
Blood, May 15, 2008; 111(10): 4841 - 4851.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J. Goffin and E. Eisenhauer
DNA methyltransferase inhibitors--state of the art
Ann. Onc., November 1, 2002; 13(11): 1699 - 1716.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Daskalakis, T. T. Nguyen, C. Nguyen, P. Guldberg, G. Kohler, P. Wijermans, P. A. Jones, and M. Lubbert
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment
Blood, September 26, 2002; 100(8): 2957 - 2964.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
V. Santini, H. M. Kantarjian, and J.-P. Issa
Changes in DNA Methylation in Neoplasia: Pathophysiology and Therapeutic Implications
Ann Intern Med, April 3, 2001; 134(7): 573 - 586.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. Wijermans, M. Lubbert, G. Verhoef, A. Bosly, C. Ravoet, M. Andre, and A. Ferrant
Low-Dose 5-Aza-2'-Deoxycytidine, a DNA Hypomethylating Agent, for the Treatment of High-Risk Myelodysplastic Syndrome: A Multicenter Phase II Study in Elderly Patients
J. Clin. Oncol., March 1, 2000; 18(5): 956 - 956.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. T. Ferguson, P. M. Vertino, J. R. Spitzner, S. B. Baylin, M. T. Muller, and N. E. Davidson
Role of Estrogen Receptor Gene Demethylation and DNA Methyltransferase·DNA Adduct Formation in 5-Aza-2'deoxycytidine-induced Cytotoxicity In Human Breast Cancer Cells
J. Biol. Chem., December 19, 1997; 272(51): 32260 - 32266.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. Gattei, A. Celetti, A. Cerrato, M. Degan, A. De Iuliis, F. M. Rossi, G. Chiappetta, C. Consales, S. Improta, V. Zagonel, et al.
Expression of the RET Receptor Tyrosine Kinase and GDNFR-alpha in Normal and Leukemic Human Hematopoietic Cells and Stromal Cells of the Bone Marrow Microenvironment
Blood, April 15, 1997; 89(8): 2925 - 2937.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1984 by American Society of Hematology         Online ISSN: 1528-0020